Role of β1-adrenoceptor in the basolateral amygdala of rats with anxiety-like behavior

Brain Research

Volumn 1211, Issue , 2008, Pages 85-92

  Fu, Ailing ^a   Li, Xiaorong ^a   Zhao, Baoquan ^b  

^a SOUTHWEST UNIVERSITY   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Anxiety; Basolateral amygdala

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; METOPROLOL; RECEPTOR SUBTYPE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BASOLATERAL MEMBRANE; CONDITIONING; CONTROLLED STUDY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TASK PERFORMANCE; WESTERN BLOTTING; ANIMAL; CONDITIONED REFLEX; DRUG EFFECT; FEAR; FLUORESCENT ANTIBODY TECHNIQUE; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; SPRAGUE DAWLEY RAT;

ANIMALIA; RATTUS;

ADRENERGIC BETA-ANTAGONISTS; AMYGDALA; ANIMALS; ANXIETY; BLOTTING, WESTERN; CONDITIONING, CLASSICAL; FEAR; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; MALE; METOPROLOL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA-1;

EID: 43049170325     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.03.013     Document Type: Article

References (46)

1. Amaral, D.G., 2002. The primate amygdale and the neurobiology of social behavior: implications for understanding social anxiety. Biol. Psychiatry 51, 11–17.
2. Aroniadou-Anderjaska, V., Qashu, F., Braga, M.F., 2007. Mechanisms regulating GABAergic inhibitory transmission in the basolateral amygdala: implications for epilepsy and anxiety disorders. Amino Acids 32, 305–315.
3. Barros, D.M., Mello e Souza, T., De David, T., Choi, H., Aguzzoli, A., Madche, C., et al., 2001. Simultaneous modulation of retrieval by dopaminergic D(1), beta-noradrenergic, serotonergic-1A and cholinergic muscarinic receptors in cortical structures of the rat. Behav. Brain. Res. 124, 1–7.
4. Braga, M.F., Aroniadou-Anderjaska, V., Manion, S.T., Hough, C.J., Li, H., 2004. Stress impairs alpha(1A) adrenoceptor-mediated noradrenergic facilitation of GABAergic transmission in the basolateral amygdala. Neuropsychopharmacology 29, 45–58.
5. Bremner, J.D., Krystal, J.H., Southwick, S.M., Charney, D.S., 1996. Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies. Synapse 23, 28–38.
6. Brunello, N., Blier, P., Judd, L.L., Mendlewicz, J., Nelson, C.J., Souery, D., et al., 2003. Noradrenaline in mood and anxiety disorders: basic and clinical studies. Int. Clin. Psychopharmacol. 18, 191–202.
7. Cao, B.J., Rodgers, R.J., 1997. Influence of 5-HT1A receptor antagonism on plus-maze behaviour in mice. I. Pindolol enantiomers and pindobind 5-HT1A. Pharmacol. Biochem. Behav. 58, 583–591.
8. Chaturvedi, S.K., 1985. Metoprolol, a new selective beta-blocker in anxiety neurosis. Psychopharmacology (Berl). 85, 488.
9. Clayton, E.C., Williams, C.L., 2000. Adrenergic activation of the nucleus tractus solitarius potentiates amygdala norepinephrine release and enhances retention performance in emotionally arousing and spatial memory tasks. Behav. Brain Res. 112, 151–158.
10. 3 adrenoceptor agonist SR58611A: Is it the putative prototype of a new class of antidepressant/anxiolytic drugs?, European Journal of Pharmacology, Volume 573, Issue 1-3, 14 November 2007, Pages 139-147.
11. Cooper, S.J., Kelly, C.B., McGilloway, S., Gilliland, A., 1990. Beta 2-adrenoceptor antagonism in anxiety. Eur. Neuropsychopharmacol. 1, 75–77.
12. Davis, M., 1992a. The role of the amygdala in fear and anxiety. Annu. Rev. Neurosci. 5, 353–375.
13. Davis, M., 1992b. The role of the amygdala in fear-potentiated startle: implications for animal models of anxiety. Trends Pharmacol. Sci. 13, 35–41.
14. Delgado, M.R., Olsson, A., Phelps, E.A., 2006. Extending animal models of fear conditioning to humans. Biol. Psychol. 73, 39–48.
15. Dennis, S., Charney, J., Bremner, D., Eugene Redmond Jr., D., 2000. Noradrenergic Neural Substrates for Anxiety and Fear: Clinical Associations Based on Preclinical Research Neuropsychopharmacology: the Fifth Generation of Progress.
16. Emilien, G., Maloteaux, J.M., 1998. Current therapeutic uses and potential of beta-adrenoceptor agonists and antagonists. Eur. J. Clin. Pharmacol. 53, 389–404.
17. Galvez, R., Mesches, M.H., McGaugh, J.L., 1996. Norepinephrine release in the amygdala in response to footshock stimulation. Neurobiol. Learn. Mem. 66, 253–257.
18. Hatfield, T., Spanis, C., McGaugh, J.L., 1999. Response of amygdalar norepinephrine to footshock and GABAergic drugs using in vivo microdialysis and HPLC. Brain Res. 835, 340–345.
19. Huff, N.C., Wright-Hardesty, K.J., Higgins, E.A., Matus-Amat, P., Rudy, J.W., 2005. Context pre-exposure obscures amygdala modulation of contextual-fear conditioning. Learn Mem. 12, 456–460.
20. Johnson, M., 1998. The beta-adrenoceptor. Am. J. Respir. Crit. Care Med. 158, S146–S153.
21. Kessler, R.C., Chiu, W.T., Demler, O., Merikangas, K.R., Walters, E.E., 2005. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62, 617–627.
22. King, D.J., Devaney, N.M., Gilbert, J.K., 1987. Double-blind placebo controlled trial of a selective beta 2 adrenoceptor antagonist (ICI 118551) in chronic anxiety. Int. Clin. Psychopharmacol. 2, 191–200.
23. LeDoux, J.E., 1992. Brain mechanisms of emotion and emotional learning. Curr. Opin. Neurobiol. 2, 191–197.
24. Maj, M., Turchan, J., Smialowska, M., Przewlocka, B., 2003. Morphine and cocaine influence on CRF biosynthesis in the rat central nucleus of amygdala. Neuropeptide 37, 105–110.
25. Mathew, S.J., Coplan, J.D., Gorman, J.M., 2001. Neurobiological mechanisms of social anxiety disorder. Am. J. Psychiatry 158, 1558–1567.
26. McKernan, M.G., Shinnick-Gallagher, P., 1997. Fear conditioning induces a lasting potentiation of synaptic currents in vitro. Nature 390, 607–611.
27. Nutt, D.J., 2001. Neurobiological mechanisms in generalized anxiety disorder. J. Clin. Psychiatry 62 (Suppl 11), 22–27 discussion 28.
28. Pandey, S.C., Zhang, H., Roy, A., Xu, T., 2005. Deficits in amygdaloid cAMP-responsive element-binding protein signaling play a role in genetic predisposition to anxiety and alcoholism. J. Clin. Invest. 115, 2762–2773.
29. Paxinos, G., Watson, C., 1998. The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego, CA.
30. Pellow, S., Chopin, P., File, S.E., Briley, M., 1985. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 14, 149–167.
31. Phan, K.L., Fitzgerald, D.A., Nathan, P.J., Tancer, M.E., 2006. Association between amygdala hyperactivity to harsh faces and severity of social anxiety in generalized social phobia. Biol. Psychiatry 59, 424–429.
32. Pietersen, C.Y., Bosker, F.J., Postema, F., den Boer, J.A., 2006. Fear conditioning and shock intensity: the choice between minimizing the stress induced and reducing the number of animals used. Lab. Anim. 40, 180–185.
33. Pitkanen, A., Pikkarainen, M., Nurminen, N., Ylinen, A., 2000. Reciprocal connections between the amygdala and the hippocampal formation, perirhinal cortex, and postrhinal cortex in rat. Ann. N.Y. Acad. Sci. 911, 369–391.
34. Quirarte, G.L., Galvez, R., Roozendaal, B., McGaugh, J.L., 1998. Norepinephrine release in the amygdala in response to footshock and opioid peptidergic drugs. Brain Res. 808, 134–140.
35. Rauch, S.L., Whalen, P.J., Shin, L.M., McInerney, S.C., Macklin, M.L., Lasko, N.B., et al., 2000. Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: a functional MRI study. Biol. Psychiatry 47, 769–776.
36. Roozendaal, B., Hui, G.K., Hui, I.R., Berlau, D.J., McGaugh, J.L., Weinberger, N.M., 2006a. Basolateral amygdala noradrenergic activity mediates corticosterone-induced enhancement of auditory fear conditioning. Neurobiol. Learn. Mem. 86, 249–255.
37. Roozendaal, B., Okuda, S., de Quervain, D.J., McGaugh, J.L., 2006b. Glucocorticoids interact with emotion-induced noradrenergic activation in influencing different memory functions Neuroscience 138, 901–910.
38. Roseboom, P.H., Klein, D.C., 1995. Norepinephrine stimulation of pineal cyclic AMP response element-binding protein phosphorylation: primary role of a beta-adrenergic receptor/ cyclic AMP mechanism. Mol. Pharmacol. 47, 439–449.
39. Rudoy, C.A., Van Bockstaele, E.J., 2007. Betaxolol, a selective β1-adrenergic receptor antagonist, diminishes anxiety-like behavior during early withdrawal from chronic cocaine administration in rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 31, 1119–1129.
40. Sonner, J.M., Xing, Y., Zhang, Y., Maurer, A., Fanselow, M.S., Dutton, R.C., et al., 2005. Administration of epinephrine does not increase learning of fear to tone in rats anesthetized with isoflurane or desflurane. Anesth. Analg. 100, 1333–1337.
41. Stein, M.B., Simmons, A.N., Feinstein, J.S., Paulus, M.P., 2007. Increased amygdala and insula activation during emotion processing in anxiety-prone subjects. Am. J. Psychiatry. 164, 318–327.
42. Stemmelin, J., Cohen, C., Terranova, J.P., Lopez-Grancha, M., Pichat, P., Bergis, O., et al., 2008. Stimulation of the beta(3)-adrenoceptor as a novel treatment strategy for anxiety and depressive disorders. Neuropsychopharmacology. 33, 574–587.
43. Tanaka, T., Yokoo, H., Mizoguchi, K., Yoshida, M., Tsuda, A., Tanaka, M., 1991. Noradrenaline release in the rat amygdala is increased by stress: studies with intracerebral microdialysis. Brain Res. 544, 174–176.
44. Tanaka, M., Yoshida, M., Emoto, H., Ishii, H., 2000. Noradrenaline systems in the hypothalamus, amygdala and locus coeruleus are involved in the provocation of anxiety: basic studies. Eur. J. Pharmacol. 405, 397–406.
45. Ugale, R.R., Sharma, A.N., Kokare, D.M., Hirani, K., Subhedar, N.K., Chopde, C.T., 2007. Neurosteroid allopregnanolone mediates anxiolytic effect of etifoxine in rats. Brain Res. 1184, 193–201.
46. Walasek, G., Wesierska, M., Werka, T., 2002. Effects of social rearing conditions on conditioned suppression in rats. Acta Neurobiol Exp. 62, 25–31.